Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma
Condition(s):Basal Cell CarcinomaLast Updated:February 11, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Basal Cell CarcinomaLast Updated:February 11, 2022Completed
Condition(s):Basal Cell Nevus Syndrome; Gorlin’s SyndromeLast Updated:November 2, 2020Completed
Condition(s):Basal Cell CarcinomaLast Updated:July 18, 2018Completed
Condition(s):Metastatic Basal Cell Carcinoma; Locally Advanced Basal Cell CarcinomaLast Updated:August 18, 2022Completed
Condition(s):Carcinoma, Basal CellLast Updated:January 29, 2020Terminated
Condition(s):Prostate CancerLast Updated:July 20, 2018Completed
Condition(s):Basal Cell CarcinomaLast Updated:May 23, 2019Completed
Condition(s):Keratocystic Odontogenic TumorLast Updated:February 18, 2021Completed
Condition(s):Advanced Basal Cell CarcinomaLast Updated:March 19, 2024Recruiting
Condition(s):Basal Cell CarcinomasLast Updated:August 14, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.